Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Share-based compensation arrangement by share-based payment award, non-option equity instruments, eExpirations, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations, Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations, Percentage Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Subsequent Event Subsequent Event [Member] Document Fiscal Year Focus Document Fiscal Year Focus July 2025 Offering July 2025 Offering [Member] July 2025 Offering Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Segment Reporting [Abstract] Common stock Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Other prepaid expenses, including from affiliated entity Other Prepaid Expense, Current Restatement Determination Date Restatement Determination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Other programs Other Programs [Member] Other Programs Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] 2007 Incentive Plan 2007 Incentive Plan [Member] 2007 Incentive Plan [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding INO-3107 INO-3107 [Member] INO-3107 Class of Warrant or Right [Table] Class of Warrant or Right [Table] Issuance of common stock warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Change in fair value of common stock warrant liabilities Change in fair value of common stock warrant liabilities Fair Value Adjustment of Warrants Contra-research and development expense Grant Proceeds Received Grant Proceeds Received Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Transfer from Level 1 to Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Entity Address, State or Province Entity Address, State or Province Series C Preferred Stock Series C Preferred Stock [Member] PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Assets: Assets, Fair Value Disclosure [Abstract] Number of shares of unvested restricted stock units and options outstanding (in shares) Number of shares outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Basic (in shares) Weighted-average common shares outstanding used to compute basic and diluted net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Common stock warrant liabilities Derivative Liability, Current Entity Address, City or Town Entity Address, City or Town Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Mutual funds Mutual Funds [Member] Mutual funds. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Title of Individual with Relationship to Entity [Domain] Title and Position [Domain] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation and Liquidity Basis of Accounting, Policy [Policy Text Block] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Number of additional securities called by warrants or rights (in shares) Class Of Warrant Or Right, Number Of Additional Securities Called By Warrants Or Rights Class Of Warrant Or Right, Number Of Additional Securities Called By Warrants Or Rights Significant Other Unobservable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Name of Property [Axis] Name of Property [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Amounts accrued for purchases of fixed assets Capital Expenditures Incurred but Not yet Paid Stock sale agreement, remaining capacity, amount Stock Sale Agreement, Remaining Capacity, Amount Stock Sale Agreement, Remaining Capacity, Amount Segment Reporting Segment Reporting [Table Text Block] Related Party [Axis] Related and Nonrelated Parties [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Research and Development Expenses - Clinical Trial Accruals Research and Development Expense, Policy [Policy Text Block] Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Service-based restricted stock units Service-Based Restricted Stock Units Service-Based Restricted Stock Units [Member] Service-Based Restricted Stock Units Schedule of Future Minimum Rental Payments for Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Stockholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name Realized loss on investments Debt Securities, Available-for-Sale, Realized Loss Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Maximum authorized amount Stock Sales Agreement, Maximum Authorized Amount Stock Sales Agreement, Maximum Authorized Amount Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Increase (decrease) in fair value of liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Operating lease liability Less: current portion Operating Lease, Liability, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Net loss per share Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Lease Expiration, Period [Domain] Lease Expiration, Period [Domain] Lease Expiration, Period [Domain] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Purchases of capital assets Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Weighted average number of common shares used to compute net loss per share Weighted Average Number of Shares Outstanding, Basic [Abstract] Net loss per share Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] 2025 Offerings 2025 Offerings [Member] 2025 Offerings Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Series A Warrants Series A Warrants [Member] Series A Warrants Related Party Transactions [Abstract] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Beginning balance (in shares) Ending balance (in shares) Shares, Issued Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Warrant Warrants to purchase common stock Warrant [Member] Diluted (in shares) Weighted-average common shares outstanding used to compute basic and diluted net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Employees and Directors Employees and Directors [Member] Employees and Directors [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Less: present value adjustment Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Award Timing Predetermined Award Timing Predetermined [Flag] Gain (loss) on investment in affiliated entity Loss (gain) on equity investment in affiliated entity Gain on investment in affiliated entity Change in Value of Investments in Affiliated Company The net result for the period of the change in fair value of the investment in affiliated entity. This investment is measured at fair value on a recurring basis. Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Quoted Prices in Active Markets (Level 1) Fair Value, Inputs, Level 1 [Member] Proceeds from exercise of warrants and pre-funded warrants Proceeds from Warrant Exercises Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Total remaining lease payments Lessee, Operating Lease, Liability, to be Paid Aggregate number of shares issued (in shares) Stock Sale Agreement, Aggregate Number of Shares Issued Stock Sale Agreement, Aggregate Number of Shares Issued 2025 Sales Agreement 2025 Sales Agreement [Member] 2025 Sales Agreement Debt Securities, Available-for-sale [Abstract] Debt Securities, Available-for-Sale [Abstract] All Executive Categories All Executive Categories [Member] Sale of stock, sales proceeds of any common stock, percentage (in percent) Sale of Stock, Sales Proceeds of Any Common Stock, Percentage Sale of Stock, Sales Proceeds of Any Common Stock, Percentage Awarded option amount Collaborative Agreement, Awarded Option Amount Collaborative Agreement, Awarded Option Amount Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Depreciation Depreciation Threshold, percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Threshold, Percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Threshold, Percentage Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Common stock warrant liabilities Common Stock Warrant Liability, Fair Value Common Stock Warrant Liability, Fair Value The Wistar Institute The Wistar Institute [Member] The Wistar Institute [Member] Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Segment Information Segment Reporting [Text Block] Short-term Investments and Fair Value Measurements Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Minimum Minimum [Member] Schedule Of Prepaid Expenses And Other Current Assets Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block] Schedule Of Prepaid Expenses And Other Current Assets Expiration Date Trading Arrangement Expiration Date Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Total liabilities Financial Liabilities Fair Value Disclosure Nonrelated Party Nonrelated Party [Member] Affiliated Entity Affiliated Entity [Member] Summary of common and preferred stock authorized, issued and outstanding Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Market-Based RSUs Restricted Stock Units (RSUs), Market-Based [Member] Restricted Stock Units (RSUs), Market-Based Proceeds from issuance of common stock, net of issuance costs Proceeds from issuance of stock Proceeds from Issuance of Common Stock Common stock, shares, authorized (in shares) Common Stock, Shares Authorized Trade accounts payable Accounts Payable, Trade Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Realized gain on investments Debt Securities, Available-for-Sale, Realized Gain Exercise Price Award Exercise Price Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Operating lease, remaining lease term (in years) Lessee, Operating Lease, Remaining Lease Term Segment Reporting [Line Items] Segment Reporting [Line Items] Total unrecognized compensation cost related to unvested stock options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] INO-3112 And Other Immuno-oncology INO-3112 And Other Immuno-oncology [Member] INO-3112 And Other Immuno-oncology Segments [Domain] Segments [Domain] Convertible preferred stock Convertible Preferred Stock [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Investment in Geneos Equity Method Investments Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Decrease in fair value recorded as a loss on investment in affiliated entity Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Consideration received on transaction Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Awarded amount Collaborative Agreement, Awarded Amount Collaborative Agreement, Awarded Amount Non Employee Non Employee [Member] Non employee. Proceeds from sale of stock Proceeds from Issuance or Sale of Equity Stock-based compensation Stock-Based Compensation [Member] Stock-Based Compensation Counterparty Name [Domain] Counterparty Name [Domain] Total Inovio Pharmaceuticals, Inc. stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Certain Balance Sheet Items Other Current Assets [Text Block] Contractual Maturity (in years) Debt Securities, Available-for-Sale Contractual Maturity Debt Securities, Available-for-sale contractual maturity. Investment in affiliated entity Equity Securities, FV-NI, Current ASSETS Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Cost Debt Securities, Available-for-Sale, Amortized Cost Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total operating lease liabilities Operating Lease, Liability December 2024 Offering Warrants December 2024 Offering Warrants [Member] December 2024 Offering Warrants Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Performance Shares Performance Shares [Member] Prepaid expenses and other current assets, including from affiliated entity Prepaid expense and other assets, current Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Dividend yield Measurement Input, Expected Dividend Rate [Member] Antidilutive securities excluded (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Proceeds from sale of investments Proceeds from Sale of Short-Term Investments Performance-and market-based restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Name of Property [Domain] Name of Property [Domain] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Income Statement [Abstract] Number of additional shares authorized (in shares) Sale Of Stock, Number Of Additional Shares Authorized Sale Of Stock, Number Of Additional Shares Authorized Document Transition Report Document Transition Report Ownership [Axis] Ownership [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Less: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Engineering and device-related Engineering And Device-Related [Member] Engineering And Device-Related Expenses to reimburse Collaborative Agreement, Expenses To Reimburse Collaborative Agreement, Expenses To Reimburse Schedule of Weighted Average Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Geneos Therapeutics, Inc. Geneos Therapeutics, Inc. [Member] Geneos Therapeutics, Inc. [Member] City Area Code City Area Code Accumulated other comprehensive loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Subsequent Events Subsequent Events [Text Block] Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Expected volatility Measurement Input, Price Volatility [Member] Collaborative Arrangement, Product Collaborative Arrangement [Member] Name Forgone Recovery, Individual Name Research And Development Cost [Domain] Research And Development Cost [Domain] Research And Development Cost [Domain] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Period over which total unrecognized compensation cost related to unvested stock options will be recognized (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Statement [Line Items] Statement [Line Items] Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Accrued clinical trial expenses Accrued Clinical Trial Expense, Current Accrued Clinical Trial Expense, Current Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Other assets Increase (Decrease) in Other Operating Assets Organization and Operations Nature of Operations [Text Block] Issuance of common stock for cash, net of financing costs (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] San Diego, California San Diego, California [Member] San Diego, California [Member] Allocated share-based compensation expense Share-Based Payment Arrangement, Expense December 2024 Offering December 2024 Offering [Member] December 2024 Offering Working capital Working Capital Working Capital Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount 2022 Inducement Plan 2022 Inducement Plan [Member] 2022 Inducement Plan Number of securities in a gross unrealized loss position Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Weighted average grant date fair value, restricted stock units (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event Type [Domain] Subsequent Event Type [Domain] Accumulated deficit Retained Earnings [Member] Operating lease liability, net of current portion Long-term operating lease liabilities Operating Lease, Liability, Noncurrent Total operating expenses Operating Expenses Research And Development Cost [Axis] Research And Development Cost [Axis] Research And Development Cost Prepaid clinical expenses Prepaid Clinical Expenses, Current Prepaid Clinical Expenses, Current Accounts Payable and Accrued Expenses [Table] Accounts Payable and Accrued Expenses [Table] Accounts Payable and Accrued Expenses Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Common stock, shares, outstanding (in shares) Common Stock, Shares, Outstanding Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Unrealized gain (loss) on short-term investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Award Timing Disclosures [Line Items] Diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other current assets, including from affiliated entity Increase (Decrease) in Prepaid Expense and Other Assets 2024 Sales Agreement 2024 Sales Agreement [Member] 2024 Sales Agreement April Series A Warrants April Series A Warrants [Member] April Series A Warrants Liabilities: Liabilities, Fair Value Disclosure [Abstract] San Diego, California San Diego Office [Member] San Diego Office [Member] Unrealized loss Unrealized Gain (Loss) on Investments Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Ownership [Domain] Ownership [Domain] Research and development Research and development expenses Research and Development Expense Area leased (in square feet) Lessee, Operating Lease, Area of Land Under Lease Lessee, Operating Lease, Area of Land Under Lease Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Revenue from collaborative arrangement Revenue from collaborative arrangement Revenue from Contract with Customer, Excluding Assessed Tax Fixed assets, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Financial Instrument [Domain] Financial Instrument [Domain] Financial Instruments [Domain] November 2025 Offering November 2025 Offering [Member] November 2025 Offering Financial assets and liabilities that are measured at fair value on recurring basis Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Period One Period One [Member] Period One Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Purchases of investments Payments to Acquire Short-Term Investments U.S. agency mortgage-backed securities Mortgage-Backed Security, Issued by US Government-Sponsored Enterprise [Member] Issuance of common stock for cash, net of financing costs Stock Issued During Period, Value, New Issues Accrued clinical trial expenses Increase (Decrease) In Accrued Clinical Trial Expense Increase (Decrease) In Accrued Clinical Trial Expense Reportable Segments Reportable Segments [Member] Reportable Segments Preferred stock Preferred Stock [Member] Class of warrant or right, common stock ownership, prior notice to issuance of shares, days Class Of Warrant Or Right, Common Stock Ownership, Prior Notice To Issuance Of Shares, Days Class Of Warrant Or Right, Common Stock Ownership, Prior Notice To Issuance Of Shares, Days Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Number of warrants exercised (in shares) Class Of Warrant Or Right, Number Of Warrants Exercised During The Period Class Of Warrant Or Right, Number Of Warrants Exercised During The Period Other accrued expenses Other Accrued Liabilities Share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Segment Reporting [Table] Segment Reporting [Table] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Title of Individual [Axis] Title and Position [Axis] Sale of Stock [Axis] Sale of Stock [Axis] Schedule of Summary of Investments Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Period Three Period Three [Member] Period Three Current Fiscal Year End Date Current Fiscal Year End Date Common Stock Warrant Liability Warrants and Rights Outstanding Investment owned (in shares) Investment Owned, Balance, Shares Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Aggregate proceeds Stock Sale Agreement, Aggregate Proceeds From Issuance Of Stock Stock Sale Agreement, Aggregate Proceeds From Issuance Of Stock Grant date fair value Share-Based Compensation Arrangement By Share-Based Payment Award, Grant Date Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Grant Date Fair Value Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Vesting of RSUs, net of tax payments Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Investment owned, fair value Investment Owned, Fair Value Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Assets, carrying value Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Basis of Presentation, Liquidity and Risks and Uncertainties Business Description and Basis of Presentation [Text Block] Schedule of Significant Assumption Used in Monte Carlo Simulation Method Schedule Of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions [Table Text Block] Schedule Of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions Equity Components [Axis] Equity Components [Axis] Related Party Related Party [Member] Class of Stock [Line Items] Class of Stock [Line Items] Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Accounts payable and accrued expenses Total Accounts payable and accrued liabilities, current Accounts Payable and Accrued Liabilities, Current Entity Small Business Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Noncontrolling Interest [Table] Noncontrolling Interest [Table] Subsequent Events [Abstract] Subsequent Events [Abstract] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other assets Other Assets, Noncurrent Document Type Document Type Fair Value as of Grant Date Award Grant Date Fair Value Other unallocated expenses Other Unallocated Expenses [Member] Other Unallocated Expenses Critical Accounting Policies and Recently Issued Accounting Standards Significant Accounting Policies [Text Block] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Operating lease right-of-use assets and liabilities, net Increase (Decrease) In Operating Lease, Right-Of-Use Asset (Lease Liability), Net Increase (Decrease) In Operating Lease, Right-Of-Use Asset (Lease Liability), Net Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Warrants and rights outstanding, measurement input Warrants and Rights Outstanding, Measurement Input Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Accounts payable and accrued expenses, including due to affiliated entity Increase (Decrease) in Accounts Payable and Accrued Liabilities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Class of warrant or right, common stock ownership, maximum percent Class Of Warrant Or Right, Common Stock Ownership, Maximum Percent Class Of Warrant Or Right, Common Stock Ownership, Maximum Percent Award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Counterparty Name [Axis] Counterparty Name [Axis] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Award Type [Domain] Award Type [Domain] Series B Warrants Series B Warrants [Member] Series B Warrants Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Remainder of 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Number of Warrants Class of Warrant or Right, Outstanding Short-term Investments and Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Supplemental disclosures: Supplemental Cash Flow Information [Abstract] Expected life in years Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Total Stockholders Return Restricted Stock Units (RSUs), Total Shareholder Return [Member] Restricted Stock Units (RSUs), Total Shareholder Return Class of warrant or right, expiration term Class Of Warrant Or Right, Expiration Term Class Of Warrant Or Right, Expiration Term Non-controlling interest (in percent) Subsidiary, Ownership Percentage, Noncontrolling Owner PEO Name PEO Name Cash, cash equivalents, and short-term investments Cash, Cash Equivalents, and Short-Term Investments Class of warrant or right, common stock ownership (in percent) Class Of Warrant Or Right, Common Stock Ownership, Percent Class Of Warrant Or Right, Common Stock Ownership, Percent Weighted-average pre-funded warrants (in shares) Incremental Common Shares Attributable To Basic And Dilutive Effect Of PreFunded Warrants Incremental Common Shares Attributable To Basic And Dilutive Effect Of PreFunded Warrants Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Liability Class [Axis] Liability Class [Axis] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Proceeds from maturity of investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] 2023 Incentive Plan 2023 Incentive Plan [Member] 2023 Incentive Plan Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Geneos Therapeutics, Inc. Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Subsequent Event [Table] Subsequent Event [Table] Collaborative agreement, amended amount Collaborative Agreement, Amended Amount Collaborative Agreement, Amended Amount Non-cash stock-based compensation Share-Based Payment Arrangement, Noncash Expense Lease cost Lease, Cost Basic (in dollars per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Underwritten Registered Direct Offering Underwritten Registered Direct Offering [Member] Underwritten Registered Direct Offering Insider Trading Arrangements [Line Items] April 2026 Offering April 2026 Offering [Member] April 2026 Offering Area of land under sublease Lessee, Operating Lease, Area of Land Under Sublease Lessee, Operating Lease, Area of Land Under Sublease Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Collaborative arrangement, term (in years) Collaborative Arrangement, Term Collaborative Arrangement, Term Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Investments in affiliated entity Equity Securities, FV-NI Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common stock Common Stock [Member] Taxes paid related to net share settlement of equity awards Proceeds From (Payments For) Stock Options Exercised and Exercise Of Warrants, Net Of Tax Withholdings Proceeds From (Payments For) Stock Options Exercised and Exercise Of Warrants, Net Of Tax Withholdings Fair Market Value Short-term investments Debt Securities, Available-for-Sale Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Equity Awards Adjustments Equity Awards Adjustments [Member] Collaborative Agreements Collaborative Arrangement Disclosure [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Accrued compensation Accrued Salaries, Current Options to purchase common stock Stock Options Share-Based Payment Arrangement, Option [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Maximum contractual term (in years) Share based Compensation Arrangement By Share based Payment Award Maximum Contractual Term Share based compensation arrangement by share based payment award maximum contractual term. Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Related Party [Domain] Related and Nonrelated Parties [Domain] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Other expense, net Other Nonoperating Income (Expense) Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Name Awards Close in Time to MNPI Disclosures, Individual Name Stockholders’ equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Plymouth Meeting, Pennsylvania Plymouth Meeting, Pennsylvania [Member] Plymouth Meeting, Pennsylvania [Member] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] General and administrative General and administrative General and Administrative Expense Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Accounts Payable and Accrued Expenses [Line Items] Accounts Payable and Accrued Expenses [Line Items] Accounts Payable and Accrued Expenses Preferred stock Preferred Stock, Value, Issued Pre-funded, exercise price (in USD per share) Class Of Warrant Or Right, Pre-Funded, Exercise Price Class Of Warrant Or Right, Pre-Funded, Exercise Price Adjustment to Compensation: Adjustment to Compensation [Axis] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Schedule of Summary of Common and Preferred Stock Authorized, Issued and Outstanding Schedule of Stock by Class [Table Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Additional revenue to be achieved Collaboration Agreement, Additional Revenue To Be Achieved Collaboration Agreement, Additional Revenue To Be Achieved Total assets measured at fair value Assets, Fair Value Disclosure Weighted-average common shares outstanding (in shares) Weighted Average Number Of Shares Outstanding Weighted Average Number Of Shares Outstanding Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Pay vs Performance Disclosure [Line Items] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Certain Balance Sheet Items [Abstract] Certain Balance Sheet Items Milestone-Based RSUs Restricted Stock Units (RSUs), Milestone-Based [Member] Restricted Stock Units (RSUs), Milestone-Based Loss on sales of short-term investments Gain (Loss) on Sale of Other Investments Expiration of warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Expiration Of Warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Expiration Of Warrants Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional paid-in capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category July 2026 Offering July 2026 Offering [Member] July 2026 Offering Short-term investments Short-Term Investments 2016 Incentive Plan 2016 Incentive Plan [Member] 2016 Incentive Plan [Member] Name Trading Arrangement, Individual Name Royalty period (in years) Collaboration Agreement, Royalty Period Collaboration Agreement, Royalty Period Cash and cash equivalents Cash and Cash Equivalent Expected life in years Measurement Input, Expected Term [Member] Class of warrant or right, common stock, prior to issuance (percent) Class Of Warrant Or Right, Common Stock Ownership, Prior To Issuance, Percent Class Of Warrant Or Right, Common Stock Ownership, Prior To Issuance, Percent Plumbline Life Sciences Plumbline Life Sciences [Member] Plumbline Life Sciences [Member] Stock-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Company Selected Measure Amount Company Selected Measure Amount Net unrealized gain on available-for-sale equity securities Net unrealized gain on available-for-sale equity securities Net unrealized gain (loss) on available-for-sale equity securities Equity Securities, FV-NI, Unrealized Gain (Loss) Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Amortization of discounts on investments Investment Income, Net, Amortization of Discount and Premium Stock sale agreement weighted average price (in dollars per share) Stock Sale Agreement, Weighted Average Price Per Share Stock Sale Agreement Weighted Average Price Per Share ApolloBio ApolloBio [Member] ApolloBio [Member] Entity Address, Address Line Two Entity Address, Address Line Two Vesting of RSUs, net of tax payments (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Current assets: Assets, Current [Abstract] Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Lessee, operating lease, base rate percentage (in percent) Lessee, Operating Lease, Base Rate Percentage, Increase (Decrease) Lessee, Operating Lease, Base Rate Percentage, Increase (Decrease) Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Lease Expiration, Period [Axis] Lease Expiration, Period [Axis] Lease Expiration, Period April Series B Warrants April Series B Warrants [Member] April Series B Warrants Award Timing Method Award Timing Method [Text Block] Decrease in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Net loss Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Schedule of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Common stock, other shares, outstanding (in shares) Common Stock, Other Shares, Outstanding Period Two Period Two [Member] Period Two Statement [Table] Statement [Table] Proceeds from issuance of warrants, net of issuance costs Proceeds from Issuance of Warrants Restatement Determination Date: Restatement Determination Date [Axis] Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Certificates of deposit Certificates of Deposit [Member] Interest income Investment Income, Interest Number of agreements to sublease Lessee, Operating Lease, Number Of Agreements To Sublease Lessee, Operating Lease, Number Of Agreements To Sublease Revenues: Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]